These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
290 related items for PubMed ID: 23528805
1. Early antibiotic discontinuation in patients with clinically suspected ventilator-associated pneumonia and negative quantitative bronchoscopy cultures. Raman K, Nailor MD, Nicolau DP, Aslanzadeh J, Nadeau M, Kuti JL. Crit Care Med; 2013 Jul; 41(7):1656-63. PubMed ID: 23528805 [Abstract] [Full Text] [Related]
2. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops. Thakkar RK, Monaghan SF, Adams CA, Stephen A, Connolly MD, Gregg S, Cioffi WG, Heffernan DS. J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560 [Abstract] [Full Text] [Related]
3. A randomized trial of diagnostic techniques for ventilator-associated pneumonia. Canadian Critical Care Trials Group. N Engl J Med; 2006 Dec 21; 355(25):2619-30. PubMed ID: 17182987 [Abstract] [Full Text] [Related]
4. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients? Eachempati SR, Hydo LJ, Shou J, Barie PS. J Trauma; 2009 May 21; 66(5):1343-8. PubMed ID: 19430237 [Abstract] [Full Text] [Related]
6. Antibiotic utilization and outcomes for patients with clinically suspected ventilator-associated pneumonia and negative quantitative BAL culture results. Kollef MH, Kollef KE. Chest; 2005 Oct 21; 128(4):2706-13. PubMed ID: 16236946 [Abstract] [Full Text] [Related]
7. Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia. Heyland DK, Dodek P, Muscedere J, Day A, Cook D, Canadian Critical Care Trials Group. Crit Care Med; 2008 Mar 21; 36(3):737-44. PubMed ID: 18091545 [Abstract] [Full Text] [Related]
8. Superinfections in Pseudomonas aeruginosa ventilator-associated pneumonia. Giantsou E, Manolas KI. Minerva Anestesiol; 2011 Oct 21; 77(10):964-70. PubMed ID: 21952596 [Abstract] [Full Text] [Related]
9. Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia. Arnold HM, Sawyer AM, Kollef MH. Respir Care; 2012 Aug 21; 57(8):1226-33. PubMed ID: 22349038 [Abstract] [Full Text] [Related]
10. The safety of targeted antibiotic therapy for ventilator-associated pneumonia: a multicenter observational study. Joffe AR, Muscedere J, Marshall JC, Su Y, Heyland DK, Canadian Critical Care Trials Group. J Crit Care; 2008 Mar 21; 23(1):82-90. PubMed ID: 18359425 [Abstract] [Full Text] [Related]
11. Early nonbronchoscopic bronchoalveolar lavage: predictor of ventilator-associated pneumonia? Minshall CT, Eriksson EA, Hawkins KS, Wolf S, Minei JP. J Trauma Acute Care Surg; 2013 Feb 21; 74(2):448-52; discussion 452-3. PubMed ID: 23354237 [Abstract] [Full Text] [Related]
12. The pathogen of ventilator-associated pneumonia does not influence the mortality rate of surgical intensive care unit patients treated with a rotational antibiotic system. Eachempati SR, Hydo LJ, Shou J, Barie PS. Surg Infect (Larchmt); 2010 Feb 21; 11(1):13-20. PubMed ID: 20163258 [Abstract] [Full Text] [Related]
13. Inappropriate antibiotic use due to decreased compliance with a ventilator-associated pneumonia computerized clinical pathway: implications for continuing education and prospective feedback. Wilde AM, Nailor MD, Nicolau DP, Kuti JL. Pharmacotherapy; 2012 Aug 21; 32(8):755-63. PubMed ID: 23307523 [Abstract] [Full Text] [Related]
14. Length of stay and hospital costs associated with a pharmacodynamic-based clinical pathway for empiric antibiotic choice for ventilator-associated pneumonia. Nicasio AM, Eagye KJ, Kuti EL, Nicolau DP, Kuti JL. Pharmacotherapy; 2010 May 21; 30(5):453-62. PubMed ID: 20411997 [Abstract] [Full Text] [Related]
15. Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy. Garnacho-Montero J, Sa-Borges M, Sole-Violan J, Barcenilla F, Escoresca-Ortega A, Ochoa M, Cayuela A, Rello J. Crit Care Med; 2007 Aug 21; 35(8):1888-95. PubMed ID: 17581492 [Abstract] [Full Text] [Related]
16. Ventilator-associated pneumonia: breaking the vicious circle of antibiotic overuse. Leone M, Garcin F, Bouvenot J, Boyadjev I, Visintini P, Albanèse J, Martin C. Crit Care Med; 2007 Feb 21; 35(2):379-85; quizz 386. PubMed ID: 17205011 [Abstract] [Full Text] [Related]
17. Guiding the management of intubated patients with pneumonia and ventilator-associated events using serial catheter-directed bronchoalveolar lavage. Stoeppel CM, Eriksson EA, Diaz-Flores R, Coffie P, Koshy J, Kacir C, Hawkins K, Minei J, Minshall C. J Trauma Acute Care Surg; 2014 May 21; 76(5):1264-9. PubMed ID: 24747458 [Abstract] [Full Text] [Related]
19. Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: a multicenter, randomized study. Chastre J, Wunderink R, Prokocimer P, Lee M, Kaniga K, Friedland I. Crit Care Med; 2008 Apr 21; 36(4):1089-96. PubMed ID: 18379232 [Abstract] [Full Text] [Related]
20. An early predictor of the outcome of patients with ventilator-associated pneumonia. Huang KT, Tseng CC, Fang WF, Lin MC. Chang Gung Med J; 2010 Apr 21; 33(3):274-82. PubMed ID: 20584505 [Abstract] [Full Text] [Related] Page: [Next] [New Search]